{
    "name": "roflumilast topical",
    "comment": "Rx",
    "other_names": [
        "Zoryve"
    ],
    "classes": [
        "PDE-4 Inhibitors",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/zoryve-roflumilast-topical-4000277",
    "pregnancy": {
        "common": [
            "There are no randomized clinical trials of oral or topical roflumilast in pregnant females ",
            "Data are not available regarding presence in human milk, effects on breastfed infants, or effects on milk production",
            "Roflumilast and/or its metabolites are excreted into the milk of lactating rats; when a drug is present in animal milk, it is likely that to be present in human milk",
            "Consider developmental and health benefits of breastfeeding along with the mother’s clinical need for treatment and any potential adverse effects on the breastfed infant"
        ],
        "specific": [
            {
                "type": "Animal studies ",
                "description": [
                    "Oral administration to pregnant rats and rabbits during organogenesis produced no fetal structural abnormalities at doses up to 9 and 8 times the maximum recommended human dose (MRHD), respectively",
                    "Roflumilast induced post-implantation loss in rats at oral doses ≥3x MRHD",
                    "Roflumilast induced stillbirth and decreased pup viability in mice at oral doses 5x and 15x MRHD, respectively",
                    "Shown to adversely affect pup post-natal development when dams were treated with oral dose 15x MRHD during pregnancy and lactation periods in mice"
                ]
            },
            {
                "type": "Clinical considerations ",
                "description": [
                    "Do not use during labor and delivery",
                    "There are no human studies that have investigated effects on preterm labor or labor at term; however, animal studies showed roflumilast PO disrupted labor and delivery process in mice"
                ]
            },
            {
                "type": "Clinical considerations ",
                "description": [
                    "Do not use during labor and delivery",
                    "There are no human studies that have investigated effects on preterm labor or labor at term; however, animal studies showed roflumilast PO disrupted labor and delivery process in mice"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Diarrhea",
            "percent": "3.1"
        },
        {
            "name": "Headache",
            "percent": "2.4"
        },
        {
            "name": "Insomnia",
            "percent": "1.4"
        },
        {
            "name": "Nausea",
            "percent": "1.2"
        },
        {
            "name": "Application site pain",
            "percent": "1"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "1"
        },
        {
            "name": "Urinary tract infection",
            "percent": "1"
        }
    ]
}